Diabetic ulcers are open wounds that appear in diabetics at the bottom of their foot. It is most commonly found in older men. Treatment of ulcers and amputations caused by these cost massive hospitalization fees and has triggered the need for effective therapies and methods. The global diabetic ulcer treatment market report by Market Research Future (MRFR) looks at amputations and neurological indications of these ulcers and predicts the future of their treatments for the period of 2019 to 2025 (forecast period).
Market Scope
The global diabetic ulcer treatment market trends is expected to display a CAGR of 8.5% over the forecast period. It was valued at USD 7500 million in 2018. The large healthcare expenditure of nations in Europe, Americas, and other developing countries can drive the market growth exponentially. Rising number of diabetics has driven the need for diabetic ulcer treatment. According to the American College of Physicians, diabetic foot ulcers statistics accounted to 6.3% cases annually. Standards outlined by healthcare organizations for getting annual foot exams annually can work in favor of the market.
Technological developments in wound care products and its subsequent adoption in healthcare organizations can fuel the market growth. Removal of dead tissues, control of blood sugar levels, and hyperbaric surgery are few treatment options for diabetic ulcers.
But high costs of diabetic ulcer treatment can restrain the market growth.
Segmentation
The global diabetic ulcer treatment has been segmented by type, treatment, and end-user.
By type, it is divided into foot ulcer and mouth ulcer. The foot ulcer segment accounted for a large share of the global market. The primary factor driving the segment growth is the complications arising due to diabetes mellitus and the large pool of patients. Use of wound dressings and biologics for lowering the rate of amputations and successful treatment of DFU can drive the diabetic foot ulcer market during the forecast period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8360
By treatment, it is segmented into active therapies, wound care dressings, and wound care devices. Wound dressing held the largest share of the market due to the large number of diabetics.
By end-user, it is segmented into academic and research organizations, hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics accounted for the largest market share due to awareness campaigns by governments and favorable reimbursement schemes. Launch of mobile applications for creating awareness among the masses has successfully driven patients towards hospitals and clinics for diabetic ulcer treatment.
Regional Analysis
Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and Americas are regions covered with respect to the global diabetic ulcer treatment market trends.
The Americas can spur the demand for diabetic ulcer treatment due to the large number of cases of diabetics. According to the American Podiatric Medical Association, close to 14-24% of Americans with diabetic foot ulcers have undergone amputations. The high potential of the combination of debridement and continuous diffusion of oxygen (CDO) has seen successful outcomes in treatment of diabetic foot ulcers (DFU).
APAC can display a robust growth rate during the forecast period owing to a large patient pool and the developing healthcare sector in India and China.
Competitive Outlook
Cardinal Health, Integra LifeSciences Corporation, ACELITY L.P. INC., Essity Aktiebolag, Smith & Nephew PLC, Organogenesis Inc., Mölnlycke Health Care AB, Braun Melsungen AG, SANUWAVE Health, Inc., ConvaTec Group PLC, and 3M are some of the notable players profiled in the global diabetic ulcer treatment market. Mergers, new product launches, and acquisitions are prime strategies of the players in the market. Recently, Organogenesis Holdings Pvt Ltd. has launched biomaterials in an effort to expand its wound dressing product line and to appeal to patient demand. Clinical trials are also being conducted to test the efficacy and performance of treatments.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/diabetic-ulcer-treatment-market-8360
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Global Diabetic Ulcer Treatment Market Research Report: By Type (Foot Ulcer, Mouth Ulcer), By Treatment (Wound Care Dressings, Wound Care Devices, Active Therapies) and By End-User (Hospitals and clinics, Ambulatory Surgical Centers, Academic and Research Organization) – Forecast to 2027Diabetic Ulcer Treatment Market ScopeDiabetic ulcers are open wounds that appear in diabetics at the bottom of their foot.
Treatment of ulcers and amputations caused by these cost massive hospitalization fees and has triggered the need for effective therapies and methods.
The global diabetic ulcer treatment market report by Market Research Future (MRFR) looks at amputations and neurological indications of these ulcers and predicts the future of their treatments for the period of 2019 to 2025 (forecast period).The global diabetic ulcer treatment market is expected to display a CAGR of 8.5% over the forecast period.
According to the American College of Physicians, diabetic foot ulcers statistics accounted to 6.3% cases annually.
Standards outlined by healthcare organizations for getting annual foot exams annually can work in favor of the diabetic ulcer treatment market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8360Technological developments in wound care products and its subsequent adoption in healthcare organizations can fuel the diabetic ulcer treatment market growth.
According to the American Podiatric Medical Association, close to 14-24% of Americans with diabetic foot ulcers have undergone amputations.
Treatment of ulcers and amputations caused by these cost massive hospitalization fees and has triggered the need for effective therapies and methods.
The global diabetic ulcer treatment market report by Market Research Future (MRFR) looks at amputations and neurological indications of these ulcers and predicts the future of their treatments for the period of 2019 to 2025 (forecast period).Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8360SegmentationThe global diabetic ulcer treatment has been segmented by type, treatment, and end-user.By type, it is divided into foot ulcer and mouth ulcer.
Use of wound dressings and biologics for lowering the rate of amputations and successful treatment of DFU can drive the diabetic foot ulcer market during the forecast period.By treatment, it is segmented into active therapies, wound care dressings, and wound care devices.
Wound dressing held the largest share of the market due to the large number of diabetics.By end-user, it is segmented into academic and research organizations, hospitals and clinics, and ambulatory surgical centers.
It was valued at USD 7500 million in 2018.
Standards outlined by healthcare organizations for getting annual foot exams annually can work in favor of the market.Technological developments in wound care products and its subsequent adoption in healthcare organizations can fuel the market growth.
The Diabetic Foot Ulcer Treatment market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
The key players in the diabetic foot ulcer treatment market include 3M Healthcare, Acelity L.P. Inc., B. Braun Melsungen AG, Coloplast A/S, ConvaTec, Inc., Medline Industries, Inc., Medtronic Plc., Molnlycke Health Care AB, Organogenesis, Inc., Smith & Nephew Plc.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Diabetic Foot Ulcer Treatment Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/Diabetic-Foot-Ulcer-Treatment-market/download-sampleMarket DynamicsThe rising prevalence of diabetes and the rapidly growing geriatric population across the globe is fueling the diabetic foot ulcer treatment market growth.
Also, the increasing number of population affected with diabetic foot ulcer disorder is further propelling the market growth.
However, the high cost of ulcer management treatment hinders market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.
